BRIEF-Actinogen Medical Ltd - U.S. FDA Grants ACW Rare Paediatric Disease Designation In FXS

Feb 5 (Reuters) - Actinogen Medical Ltd ACW.AX:

• FDA GRANTS ACW RARE PAEDIATRIC DISEASE DESIGNATION IN FXS-ACW.AX

• U.S. FDA GRANTED ACTINOGEN'S DRUG XANAMEM RARE PAEDIATRIC DISEASE DESIGNATION (RPDD) FOR TREATMENT OF FRAGILE X SYNDROME (FXS)

Source text for Eikon: ID:nASX9jbSNz

Further company coverage: ACW.AX

((Reuters.Briefs@thomsonreuters.com;))